awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38373931-F25AB29E-F0C7-4992-8BCB-E359D7A6F787
Q38373931-F25AB29E-F0C7-4992-8BCB-E359D7A6F787
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38373931-F25AB29E-F0C7-4992-8BCB-E359D7A6F787
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
P2860
Q38373931-F25AB29E-F0C7-4992-8BCB-E359D7A6F787
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38373931-F25AB29E-F0C7-4992-8BCB-E359D7A6F787
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfd399d03ac66fb04e96236ccd82dc72d2f65e92
P2860
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours.